日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Blinatumomab in de novo AYA ALL-Results of the Australasian Leukaemia and Lymphoma Group ALL09 "SUBLIME" study

Blinatumomab治疗新发AYA ALL——澳大利亚白血病和淋巴瘤协作组ALL09“SUBLIME”研究结果

Greenwood, Matthew; Gangatharan, Shane; Osborn, Michael; Ng, Ashley P; Fleming, Shaun; Fedele, Pasquale; Trahair, Toby; Casey, John; Mapp, Sally; Cheung, Carol; Armytage, Tasman; Henderson, Michelle; Sutton, Rosemary; Rehn, Jacqueline; Page, Elyse; Heatley, Susan; Button, Peter; Rowley, Leesa; Larsen, Stephen R; Presgrave, Peter; Kwan, John; Bennett, Samuel; Fong, Chun Yew; Dalla Pozza, Luciano; Yeung, David; White, Deborah

A qualitative study on blood and marrow transplant recipients' perceptions of health professional roles following BMT and preferences for ongoing care

一项关于血液和骨髓移植受者对骨髓移植后医护人员角色认知及后续护理偏好的定性研究

McErlean, Gemma; Ashley, Christine; Pradhan, Anisha; Yenson, Vanessa; Paterson, Alana; Farnham, Gai; Owen, Fran; Watson, Anne-Marie; Presgrave, Peter; Kerridge, Ian; Halcomb, Elizabeth

Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs.

MDS 对阿扎胞苷的临床反应与 HSPC 中独特的 DNA 甲基化变化有关

Thoms Julie A I, Yan Feng, Hampton Henry R, Davidson Sarah, Joshi Swapna, Saw Jesslyn, Sarowar Chowdhury H, Lim Xin Ying, Nunez Andrea C, Kakadia Purvi M, Bhuyan Golam Sarower, Zou Xiaoheng, Nguyen Mary, Ghodousi Elaheh S, Koch Forrest C, Vafaee Fatemeh, Thompson I Richard, Karimi Mohammad M, Pickford Russell, Raftery Mark J, Hough Sally, Buckland Griselda, Bailey Michelle, Ghodke Yuvaraj, Absar Noorul, Vaughan Lachlin, Pasalic Leonardo, Fong Chun Y, Kenealy Melita, Hiwase Devendra K, Stoddart Rohanna I, Mohammed Soma, Lee Linda, Passam Freda H, Larsen Stephen R, Spring Kevin J, Skarratt Kristen K, Rebeiro Patricia, Presgrave Peter, Stevenson William S, Ling Silvia, Tiley Campbell, Fuller Stephen J, Roncolato Fernando, Enjeti Anoop K, Hoenemann Dirk, Lemech Charlotte, Jolly Christopher J, Bohlander Stefan K, Curtis David J, Wong Jason W H, Unnikrishnan Ashwin, Hertzberg Mark, Olivier Jake, Polizzotto Mark N, Pimanda John E

Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive After Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study

在复发性滤泡性淋巴瘤治疗后PET显像仍呈阳性的患者中,利妥昔单抗维持治疗联合来那度胺巩固治疗:一项澳大利亚白血病和淋巴瘤组NHL26 II期研究

Trotman, Judith; Presgrave, Peter; Carradice, Duncan P; Lenton, Douglas Stuart; Gandhi, Maher K; Cochrane, Tara; Badoux, Xavier; Carlson, Julia; Nkhoma, Gloria; Butcher, Belinda; Nikpour, Armin; Fulham, Michael; Johnston, Anna M

Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma

与多发性骨髓瘤患者高剂量美法仑暴露量试验剂量药代动力学预测相关的挑战

Nath, Christa Ellen; Grigg, Andrew; Rosser, Sebastian P A; Estell, Jane; Newman, Elizabeth; Tiley, Campbell; Ramanathan, Sundra; Ho, Shir Jing; Larsen, Stephen; Gibson, John; Presgrave, Peter; Shaw, Peter John; Trotman, Judith